Is Black Diamond Therapeutics, Inc. (BDTX) a Buy, Sell, or Hold?
NASDAQ : BDTX
Black Diamond Therapeutics, Inc. — Analyst Ratings
$1.905 USD
$0.12 (6.42%)
- Volume
- 351.86K
- Average Volume
- 1.69M
- Market Capitalization
- $109.16M
- P/E Ratio
- -2.57
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $4.94
- Year Low
- $1.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.28
Analyst Consensus Summary
Consensus Rating
Neutral
11 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-79.9%
vs Current Price
Price Target
$9.50
Average TargetPrice Target Range
Lowest Target
$8.00
-76.2% DOWNSIDE
Average Target
$9.50
Median Estimate
Highest Target
$20.00
-90.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Kelsey Goodwin | $8 | $2.67 | 2026-01-16 06:54 AM | 199.6% |
| Stifel Nicolaus | Laura Prendergast | $8 | $4.14 | 2025-10-15 04:31 PM | 93.2% |
| Guggenheim | Brad Canino | $8 | $2.88 | 2025-09-03 04:15 PM | 177.8% |
| Raymond James | Laura Prendergast | $20 | $5.91 | 2024-07-31 04:18 AM | 238.4% |
| Piper Sandler | Joseph Calanzaro | $12 | $4.7839 | 2024-06-03 04:52 AM | 150.8% |
| H.C. Wainwright | Robert Burns | $11 | $5.44 | 2024-05-16 02:12 AM | 102.2% |
| Wedbush | Robert Driscoll | $16 | $5.06 | 2024-04-08 03:07 AM | 216.2% |
| H.C. Wainwright | Raghuram Selvaraju | $12 | $4.7 | 2024-03-18 02:38 AM | 155.3% |